Benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide
C16H24INO2 — CID 141382703
Data last refreshed: (MolForge compound catalog, from PubChem)
About Benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide
Benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide (PubChem CID 141382703) has the molecular formula C16H24INO2 and a molecular weight of 389.28 g/mol. Its IUPAC name is benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide.
Molecular Properties
| Compound Name | Benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide |
|---|---|
| PubChem CID | 141382703 |
| Molecular Formula | C16H24INO2 |
| Molecular Weight | 389.28 g/mol |
| Exact Mass | 389.09 |
| IUPAC Name | benzyl-ethyl-methyl-(3-prop-2-enoyloxypropyl)azanium iodide |
| SMILES | C=CC(=O)OCCC[N+](C)(CC)Cc1ccccc1.[I-] |
| InChI | InChI=1S/C16H24NO2.HI/c1-4-16(18)19-13-9-12-17(3,5-2)14-15-10-7-6-8-11-15;/h4,6-8,10-11H,1,5,9,12-14H2,2-3H3;1H/q+1;/p-1 |
| InChIKey | ISBZOMDMZKWKDU-UHFFFAOYSA-M |
| XLogP | -0.22 |
| TPSA | 26.30 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.28 |
| LogP ≤ 5 | -0.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141382703 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.